Thrombolytic therapy with tissue-type pl
โ
Glenn R. Larsen; Elliot S. Barnathan
๐
Article
๐
1991
๐
Elsevier Science
๐
English
โ 846 KB
Tissue-type plasminogen activator produced by recombinant DNA technology, has been established as an important thrombolytic agent in the treatment of acute myocardial infarction. New approaches to increase the effectiveness of this agent, including rapid high dose administration are being investigat